Skip to main content
Premium Trial:

Request an Annual Quote

Cy Stein, Douglas Liu, James Vincent, Matthew Moore, Robert Embree, John Besser, Shaf Yousaf, David Julien, Gilles Cottier


Qiagen said this week that Douglas Liu has joined the company as vice president of global operations. Liu will oversee all of Qiagen's operations including manufacturing, quality, logistics, and infrastructure.

Liu most recently was head of operations for nucleic acid diagnostics in the US for Bayer Healthcare, and also worked in strategic planning and consulting for Bayer AG, Qiagen said. Before his time at Bayer, he held positions at Abbott Diagnostics and Chiron Diagnostics.

Liu holds an MBA from Boston University and a BS from the University of Illinois.

Alnylam Pharmaceuticals said recently that James Vincent has been appointed as a director.

Vincent was formerly CEO and chairman of Biogen, a company co-founded by Alnylam co-founder and MIT researcher Phillip Sharp. Before his time there, Vincent served in a number of managerial roles at Allied-Signal, Abbott Laboratories, and Texas Instruments, Alnylam said.

CombiMatrix Molecular Diagnostics has added three people to its management team:

Matthew Moore has become director of research and development. He joins CMD from US LABS, where he was part of the research and development team. Moore holds a PhD from the University of New South Wales in Australia.

Robert Embree has become director of laboratory operations. Previously, he was managing director of global immunohistochemistry and virtual image analysis of US LABS. He holds a BS from the University of Redlands in Southern California.

John Besser has joined CMD as chief financial officer. He comes to CMD from the Quest Diagnostics Nichols Institute, where he served as controller. Besser holds a BS in business management from the University of Utah.

Sigma-Aldrich announced several internal management changes in connection with its recent reorganization:

Shaf Yousaf, vice president of corporate R&D and biotechnology marketing, will become president of the firm's new Biotech unit.

David Julien, most recently president of Sigma's biotechnology business, was named president of the new Specialties unit.

Gilles Cottier, vice president of sales at Sigma, was appointed president of the new Essentials unit.

The firm's SAFC business unit will continue to be led by Frank Wicks, who has served as its president since January 2003.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.